ArticleBrain and behavior2026
Aberrant Brain Entropy in Alzheimer's Disease: Evidence From a Resting-State fMRI Study.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe neurodegenerative disorder, Alzheimer's disease (AD), is typified by insidious onset and increasing prevalence with advancing age. It primarily causes comprehensive functional decline in memory, language, and executive control. The scarcity of reliable imaging biomarkers has led to resting-state functional magnetic resonance imaging (rs-fMRI) becoming a seminal tool for investigating functional alterations in neurological disorders. Brain entropy (BEN) is an indicator derived from rs-fMRI data, quantifying the complexity of functional brain activity and the uncertainty of spontaneous activity. This study aims to utilize BEN technology to elucidate the spatial distribution characteristics of functional complexity within the brains of AD patients.
methodsThe present study comprised 30 patients diagnosed with AD and 46 healthy controls recruited from the same center. A comprehensive neuropsychological assessment and rs-fMRI data acquisition were carried out for all participants. Intergroup comparisons were conducted using voxel-level BEN value maps. To this end, a partial correlation analysis was conducted with the objective of ascertaining the association between BEN values in regions exhibiting significant intergroup differences and cognitive function scores.
resultThis study found significantly decreased BEN in the right superior temporal gyrus, right inferior frontal gyrus, and left posterior parietal gyrus among patients with AD, which was significantly correlated with MMSE and MoCA cognitive scores. Exploratory analyses also revealed abnormal trends in the precuneus, cuneus, and left frontotemporal pole.
conclusionA widespread reduction in BEN was observed in cerebral regions implicated in language memory, processing, and integrative functions, consistent with cognitive decline in AD. As a sensitive and noninvasive metric, BEN shows promise as an imaging marker for early screening and monitoring of AD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.